Literature DB >> 15532030

Coexpression of Brn-3a POU protein with p53 in a population of neuronal progenitor cells is associated with differentiation and protection against apoptosis.

Chantelle D Hudson1, Jennifer Podesta, Deborah Henderson, D S Latchman, V Budhram-Mahadeo.   

Abstract

The Brn-3a transcription factor is critical for survival and differentiation of sensory neurons derived from neural crest cells (NCC). Interaction of Brn-3a with p53 results in differential effects on target gene expression, which profoundly affects fate of neuronal cells. Here we demonstrate colocalization of p53 in a subset of Brn-3a-positive NCC-derived cells fated for the sensory neuronal lineage. The distinct morphology of Brn-3a/p53-coexpressing cells suggested a differentiated neuronal cell type, and this was confirmed by colocalization of p53 with differentiation marker NF-160. Functional effects of Brn-3a/p53 coexpression were analyzed in NCC cultured from Brn-3a -/- embryos, which showed significantly increased apoptosis upon induction of p53 compared with wild-type NCC, suggesting that Brn-3a modulates the p53-mediated fate of NCC that coexpress both factors. Thus, p53 is expressed in neuronal cells undergoing differentiation as well as apoptosis. Interaction with Brn-3a in sensory neurons may be critical for modulating p53-mediated gene expression and hence cell fate. (c) 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15532030     DOI: 10.1002/jnr.20299

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  9 in total

1.  The tumor suppressor protein p53 is required for neurite outgrowth and axon regeneration.

Authors:  Simone Di Giovanni; Chad D Knights; Mahadev Rao; Alexander Yakovlev; Jeannette Beers; Jason Catania; Maria Laura Avantaggiati; Alan I Faden
Journal:  EMBO J       Date:  2006-08-31       Impact factor: 11.598

2.  Axotomy-induced early down-regulation of POU-IV class transcription factors Brn-3a and Brn-3b in retinal ganglion cells.

Authors:  Jochen H Weishaupt; Nikolaj Klöcker; Mathias Bähr
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

Review 3.  Transcription factors and neural stem cell self-renewal, growth and differentiation.

Authors:  Sohail Ahmed; Hui Theng Gan; Chen Sok Lam; Anuradha Poonepalli; Srinivas Ramasamy; Yvonne Tay; Muly Tham; Yuan Hong Yu
Journal:  Cell Adh Migr       Date:  2009-10-27       Impact factor: 3.405

Review 4.  Epigenetic setting and reprogramming for neural cell fate determination and differentiation.

Authors:  Takuya Imamura; Masahiro Uesaka; Kinichi Nakashima
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-09-26       Impact factor: 6.237

5.  Cardiac expression of Brn-3a and Brn-3b POU transcription factors and regulation of Hsp27 gene expression.

Authors:  Saleha R Farooqui-Kabir; James K J Diss; Deborah Henderson; Michael S Marber; David S Latchman; Vishwanie Budhram-Mahadeo; Richard J Heads
Journal:  Cell Stress Chaperones       Date:  2008-03-27       Impact factor: 3.667

6.  Essential but partially redundant roles for POU4F1/Brn-3a and POU4F2/Brn-3b transcription factors in the developing heart.

Authors:  Lauren J Maskell; Kashif Qamar; Aram A Babakr; Thomas A Hawkins; Richard J Heads; Vishwanie S Budhram-Mahadeo
Journal:  Cell Death Dis       Date:  2017-06-08       Impact factor: 8.469

7.  Identification of contributing genes of Huntington's disease by machine learning.

Authors:  Jack Cheng; Hsin-Ping Liu; Wei-Yong Lin; Fuu-Jen Tsai
Journal:  BMC Med Genomics       Date:  2020-11-23       Impact factor: 3.063

8.  Brn-3b enhances the pro-apoptotic effects of p53 but not its induction of cell cycle arrest by cooperating in trans-activation of bax expression.

Authors:  Vishwanie S Budhram-Mahadeo; Samantha Bowen; Sonia Lee; Christina Perez-Sanchez; Elizabeth Ensor; Peter J Morris; David S Latchman
Journal:  Nucleic Acids Res       Date:  2006-12-01       Impact factor: 16.971

9.  The neural crest transcription factor Brn3a is expressed in melanoma and required for cell cycle progression and survival.

Authors:  Tobias Hohenauer; Carola Berking; Andreas Schmidt; Sebastian Haferkamp; Daniela Senft; Claudia Kammerbauer; Sabine Fraschka; Saskia Anna Graf; Martin Irmler; Johannes Beckers; Michael Flaig; Achim Aigner; Sabrina Höbel; Franziska Hoffmann; Heiko Hermeking; Simon Rothenfusser; Stefan Endres; Thomas Ruzicka; Robert Besch
Journal:  EMBO Mol Med       Date:  2013-05-13       Impact factor: 12.137

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.